Diagnosticos da America (Dasa) plans to buy back $218m (87%) of its outstanding 2018 bonds, it says, following the closing of a tender offer. The Brazilian medical diagnostics company plans to swap legacy dollar debt incurred under previous management with local funds. It had offered holders $1,150 per $1,000 principal if they accepted before the December 1 early deadline, or $1,120 per $1,000 after that. Dasa plans to cover the costs of the repurchase with local bank loans and credit lines, according to a banker on the trade. Itau is managing the offer. Dasa originally sold the $250m of 2018s in May 2008, its debut in the cross-border markets, through Credit Suisse and Merrill Lynch.